β-Methyl-2C-B (BMB), also known as 4-bromo-2,5-dimethoxy-β-methylphenethylamine, is a psychoactive drug of the phenethylamine and 2C families related to the BOx drugs. It is the β-methyl derivative of 2C-B and a structural isomer of DOB (α-methyl-2C-B), but is less potent than either of these drugs. The drug has around half the potency of 2C-B itself, with effects occurring at a dose of around 20mg orally and with a duration of approximately 8hours. Moreover, its effects were described as very different from those of 2C-B and effects typical of 2C-B were said to be largely absent. It has two possible enantiomers but their activity has not been tested separately. BMB was described by Daniel Trachsel in his 2013 book Phenethylamine: Von der Struktur zur Funktion (Phenethylamines: From Structure to Function). It may be a controlled substance in Canada. The drug is not an explicitly controlled substance in the United States.
See also BOx (psychedelics) 2C (psychedelics) β-Methyl-DOM βk-2C-B (β-keto-2C-B) and BOB (β-methoxy-2C-B) DMCPA, 2CB-Ind, and TCB-2 ZC-B, 2C-B-PYR, and LPH-5
References
External links BMB - Isomer Design